178 related articles for article (PubMed ID: 22550209)
1. Update in cystic fibrosis 2011.
Ratjen F; McColley SA
Am J Respir Crit Care Med; 2012 May; 185(9):933-6. PubMed ID: 22550209
[No Abstract] [Full Text] [Related]
2. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
[No Abstract] [Full Text] [Related]
3. A liposome model to treat pseudomonas in lungs of cystic fibrosis and immune compromised patients.
Yatvin MB
Cell Mol Biol Lett; 2002; 7(2):304. PubMed ID: 12097974
[No Abstract] [Full Text] [Related]
4. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic choice for Pseudomonas pulmonary infections in children with cystic fibrosis.
Bingen E
Pediatr Pulmonol Suppl; 1997; 16():45. PubMed ID: 9443192
[No Abstract] [Full Text] [Related]
7. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
[TBL] [Abstract][Full Text] [Related]
8. Update in cystic fibrosis 2009.
Mogayzel PJ; Flume PA
Am J Respir Crit Care Med; 2010 Mar; 181(6):539-44. PubMed ID: 20208039
[No Abstract] [Full Text] [Related]
9. Pseudomonas infections in cystic fibrosis.
George RH
Arch Dis Child; 1987 May; 62(5):438-9. PubMed ID: 3111389
[No Abstract] [Full Text] [Related]
10. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
[No Abstract] [Full Text] [Related]
11. [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].
Guillot M; Amiour M; El Hachem C; Harchaoui S; Ribault V; Paris C
Arch Pediatr; 2006 Oct; 13 Suppl 1():S48-50. PubMed ID: 17370396
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis: intravenous treatment at home.
Catchpole A
Nurs Times; 1989 Mar 22-28; 85(12):40-2. PubMed ID: 2717454
[No Abstract] [Full Text] [Related]
13. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report.
Scott AI; Clarke BE; Healy H; D Emden M; Bell SC
JOP; 2000 Nov; 1(4):208-10. PubMed ID: 11856863
[TBL] [Abstract][Full Text] [Related]
14. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
[TBL] [Abstract][Full Text] [Related]
15. Invasive pneumonia and septic shock in infants as a presentation of cystic fibrosis with vitamin-deficiency.
Al-Khadra ES; Chau KW; Barone CP; Colin AA
Pediatr Pulmonol; 2012 Jul; 47(7):722-6. PubMed ID: 22684986
[TBL] [Abstract][Full Text] [Related]
16. [Physiopathology of cystic fibrosis and of infections associated to this disease].
Aramă SS; Aramă V; Cercel AS; Ion DA; Hristea A; Sotcan M
Pneumologia; 2007; 56(4):202-7. PubMed ID: 18320796
[TBL] [Abstract][Full Text] [Related]
17. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis.
Amin R; Lam M; Dupuis A; Ratjen F
Pediatr Pulmonol; 2011 Jun; 46(6):554-8. PubMed ID: 21337727
[TBL] [Abstract][Full Text] [Related]
18. Inhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Korbila IP; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Pulmonol; 2010 Nov; 45(11):1135-40. PubMed ID: 20658485
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
Kerrebijn KF; Mouton J
Acta Univ Carol Med (Praha); 1990; 36(1-4):28-33. PubMed ID: 2130712
[No Abstract] [Full Text] [Related]
20. A ten year review of colomycin.
Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
